Review | Quality assessment undertaken and method | Findings presented/use of summary score | Findings used in context of results/sensitivity analysis | Comment |
---|---|---|---|---|
Canivano and Gracia [10] | None | N/A | N/A | |
HTA report [8] | Quality assessment tool derived from QUADAS [19] and the Hayden checklist relating to prognostic studies [20] | Results of the quality assessment were presented | Impact commented on but sensitivity analyses not deemed possible. | |
Krasopoulos et al. [11] | Study eligibility criterion: investigators to be blinded to patients’ aspirin status | Quality rating for risk of bias (A to D) but not explicit on how this was derived | No | Terminology used was confusing (e.g. ‘allocation of blindness’ and ‘compliance with blindness’). The term ‘allocation concealment’ used in the context of observational studies is not appropriate |
Li et al. [15] | Study eligibility criterion: only those studies with verified compliance. Newcastle-Ottawa checklist [21] for cohort studies | Findings presented | No | |
Pusch et al. [12] | None | N/A | N/A | |
Sofi et al. [14] | Study eligibility criterion: prospective study design | N/A | N/A | |
Snoep et al. [13] | Quality criteria relating to: control for confounders, measurement of exposure, completeness of follow-up and blinding, and, for case–control studies, matching and case definition | No | No | |
Wisman et al. [16] | Modified QUADAS tool [19] (for quality assessment of diagnostic accuracy studies). 11 items assessed | Findings presented | Sensitivity analysis. Studies scoring ‘low risk of bias’ on eight or more of the quality items were considered to be good quality |